Paladin Wealth LLC Purchases New Shares in Cardinal Health, Inc. $CAH

Paladin Wealth LLC purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 1,202 shares of the company’s stock, valued at approximately $202,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Greykasell Wealth Strategies Inc. acquired a new position in shares of Cardinal Health in the 1st quarter valued at $26,000. Jones Financial Companies Lllp boosted its position in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the period. Tompkins Financial Corp boosted its position in Cardinal Health by 106.7% during the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company’s stock worth $34,000 after acquiring an additional 128 shares during the period. GW&K Investment Management LLC boosted its position in Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after acquiring an additional 144 shares during the period. Finally, NBC Securities Inc. acquired a new stake in Cardinal Health during the 1st quarter worth about $48,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on CAH shares. UBS Group restated a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Evercore ISI decreased their price objective on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research report on Wednesday, August 13th. Argus set a $189.00 price objective on Cardinal Health in a research report on Friday, August 22nd. Wall Street Zen lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 2nd. Finally, Citigroup restated a “neutral” rating and set a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Eleven analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $165.93.

Cardinal Health Price Performance

CAH opened at $152.34 on Monday. Cardinal Health, Inc. has a fifty-two week low of $106.54 and a fifty-two week high of $168.44. The business has a 50-day moving average of $154.50 and a 200-day moving average of $147.93. The company has a market capitalization of $36.38 billion, a PE ratio of 23.62, a price-to-earnings-growth ratio of 1.29 and a beta of 0.73.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same period last year, the business earned $1.84 EPS. The firm’s revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.63%.

Insiders Place Their Bets

In related news, CEO Stephen M. Mason sold 41,575 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the transaction, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares in the company, valued at $7,211,370.74. The trade was a 44.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock worth $40,489,525 in the last three months. 0.09% of the stock is owned by insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.